Major Growth Driving Factors:
The growing target patient population, ongoing product development, and commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across the emerging markets, growth in market demand for effective neurovascular devices, increase in research in the field of neurovascular therapies, rise in demand for minimally invasive neurosurgical procedures, and increase in awareness among neurosurgeons about minimally invasive surgical procedures are high growth prospects for the Neurovascular Devices Market during the forecast period.
Global Leading Companies:
A few major players that have an extensive geographic presence dominate the interventional neurology industry globally. The leading players in the neurovascular devices market include Johnson & Johnson (US), Medtronic PLC Ireland, Stryker Corporation (US), Terumo Corporation (Japan), Penumbra, Inc. (US), Microport Scientific Corporation (China), Kaneka Corp. (Japan), Integer Holdings Corporation, Balt (France), Perflow Medical, and Phenox GmbH (Germany), among others.
Growth Strategies Adopted by Them:
The major strategies adopted by these players include new product launches, collaborations & agreements, mergers, investments & expansions. New product launches was the most commonly adopted strategy from January 2018 to March 2021.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=847
In 2020, Stryker Corporation was the largest player in the neurovascular devices/ interventional neurology market, owing to its wide portfolio of neurovascular products and strong geographical presence across the globe. The company primarily focuses on developing technologically advanced products for interventional neurology. The company has a strong presence across North America, Europe, the Middle East, Africa, Asia Pacific, and other countries.
The company has more than 30 manufacturing facilities in countries such as the US, China, Turkey, Germany, Ireland, Switzerland, and France. It primarily focuses on inorganic business growth strategies such as product development & commercialization, acquisitions, and market expansions. As a part of its long-term growth strategy, the company invests in fast-growing markets as well as new markets by strengthening its position in the global healthcare market.
In 2020, Medtronic plc was the second-largest player in the neurovascular devices/ interventional neurology market. The company has a strong geographical presence and offers a broad range of products that are integral to the interventional neurology market, which includes embolic coils, microcatheters, guidewires, balloon catheters, liquid embolics, aspiration catheters, clot retrieval devices, flow diversion devices, vascular embolization devices, remodeling devices, and flow restoration devices.
In order to strengthen its current position and to gain a larger share in the neurovascular devices/interventional neurology market, the company aggressively focuses on inorganic growth strategies, such as product development & commercialization, acquisitions, and market expansions.
Terumo Corporation (Japan) is one of the key players in the neurovascular devices/ interventional neurology market, owing to its robust portfolio and wide geographical presence. The company focuses on both organic and inorganic strategies to strengthen its position in the market. The company continues to view acquisitions as a major part of its growth strategy. These acquisitions are intended to augment growth, expand its business with new technologies and products, and enhance its geographical reach.
The company’s strong research and development (R&D) capabilities enable it to produce innovative products that meet customers’ expectations. It invests a significant part of its total revenue in R&D activities to strengthen internal development capabilities and deliver novel products in the market.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=847
North America is expected to be the largest market during the forecast period.
North America is estimated to be the largest market for neurovascular devices during the forecast period. The neurovascular devices market in North America is driven primarily by factors such as the significant disease burden, increased number of minimally invasive neurology procedures, and continued expansion of trauma/emergency care facilities in US.
The ambulatory care centers segment is expected to grow at the highest CAGR during the forecast period.
Based on end-user, the neurovascular devices market has been segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories, and academic institutes. As of 2020, hospitals & surgical centers are estimated to account for the largest share of the global market in 2021, while ambulatory care centers are projected to register the highest CAGR during the forecast period. Growing patient preference for minimally invasive medical procedures, rising number of ambulatory surgery centers across developed countries, along with the ease of scheduling, the focused clinical staff, the improved productivity, and the increased safety, and efficacy of these centers, are the major factors that are expected to drive the growth of this end-user segment in the coming years.
